The synthesis of hollow Ag nanoshells (NSs) with tunable plasmon bands in the visible spectrum and their oxidative-assembly into high-surface-area, mesoporous, transparent, and opaque Ag gel frameworks is reported. Thiolate-coated Ag NSs with varying size and shell thickness were prepared by fast chemical reduction of preformed Ag2O nanoparticles (NPs). These NSs were assembled into monolithic Ag hydrogels via oxidative removal of the surface thiolates, followed by CO2 supercritical drying to produce metallic Ag aerogels. The gelation kinetics have been controlled by tuning the oxidant/thiolate molar ratio (X) that governs the rate of NP condensation, which in turn determines the morphology, optical transparency, opacity, surface area, and porosity of the resultant gel frameworks. The monolithic Ag hydrogels prepared using high concentration of oxidant (X > 7.7) leads to oxidative etching of precursor colloids into significantly smaller NPs (3.2-7.6 nm), which appeared to eliminate the visible light scattering yielding transparent gel materials. In contrast, the opaque Ag aerogels composed entirely of hollow NSs exhibit enormously high surface areas (45-160 m(2)/g), interconnected meso-to-macro-pore network that can be tuned by varying the inner cavity of Ag colloids, and accessibility of chemical species to both inner and outer surface of the hollows, offering perspectives for a number of new technologies. An advantage of current synthesis is the ability to transform Ag NSs into monolithic hydrogels within 4-12 h, which otherwise is reported to require weeks to months for the oxidation-induced metallic gel synthesis reported to date.
In photodynamic therapy (PDT), the level of reactive oxygen species (ROS) produced in the cell directly determines the therapeutic effect. Improvement in ROS concentration can be realized by reducing the glutathione (GSH) level or increasing the amount of photosensitizer. However, excessive amounts photosensitizer may cause side effects. Therefore, the development of photosensitizers that reduce GSH levels through synergistically improving ROS concentration in order to strengthen the efficacy of PDT for tumor is important. We report a nano-metal-organic framework (Cu -metalated nano-MOF {CuL-[AlOH] } (MOF-2, H L=mesotetrakis(4-carboxylphenyl)porphyrin)) based on Cu as the active center for PDT. This MOF-2 is readily taken up by breast cancer cells, and high levels of ROS are generated under light irradiation. Meanwhile, intracellular GSH is considerably decreased owing to absorption on MOF-2; this synergistically increases ROS concentration and accelerates apoptosis, thereby enhancing the effect of PDT. Notably, based on the direct adsorption of GSH, MOF-2 showed a comparable effect with the commercial antitumor drug camptothecin in a mouse breast cancer model. This work provides strong evidence for MOF-2 as a promising new PDT candidate and anticancer drug.
Clinical cancer treatments nowadays still face the challenge of recurrence due to the residual cancer cells and minute lesions in surgeries or chemotherapies. To effectively address the problem, we introduce a strategy for constructing cancer cell nuclear-targeted copper sulfide nanoparticles (NPs) with a significant photothermal effect to completely kill residual cancer cells and prevent local cancer recurrence. The NPs could directly target the tumor cells and further enter the nucleus by the surface modification of RGD and TAT peptides. Under the irradiation of 980 nm near-infrared laser, the NPs rapidly increase the temperature of the nucleus, destroy the genetic substances, and ultimately lead to an exhaustive apoptosis of the cancer cells. In vivo experiments show that the designed NPs could effectively treat cancer and prevent the return of cancer with a single laser irradiation for 5 min. The photothermal therapy strategy with nuclear targeting for cancer therapy and anti-recurrence will provide more possibilities to develop efficient platforms for treating cancer.
Bimetallic alloy aerogels (Au/Ag, Pd/Ag, Pt/Ag) have been prepared from a novel approach that involves the salt-mediated self-assembly of metal nanoshells followed by supercritical drying. These materials can be prepared as large (centimeter to inch) self-supported monoliths within a day, and the gelation kinetics can be tuned by engineering the in-situ-generated ionic strength of the precursor colloids. Resultant aerogels exhibit a continuous mesopore-to-macropore network that can be altered by the inner diameter of the precursor nanoshells and the accessibility of molecules to the inner surface of the hollows, offering new perspectives for their applications in advanced technologies. The attractive nature of this new strategy is the ability to increase the rate of self-assembly, which otherwise is an intrinsically sluggish process in the oxidation-induced NP assembly reported to date.
Gold nanoparticles (Au NPs) assembled through Au-S covalent bonds have been widely used in biomolecule-sensing technologies. However, during the process, detection distortions caused by high levels of thiol compounds can still significantly influence the result and this problem has not really been solved. Based on the higher stability of Au-Se bonds compared to Au-S bonds, we prepared selenol-modified Au NPs as an Au-Se nanoplatform (NPF). Compared with the Au-S NPF, the Au-Se NPF exhibits excellent anti-interference properties in the presence of millimolar levels of glutathione (GSH). Such an Au-Se NPF that can effectively avoid detection distortions caused by high levels of thiols thus offers a new perspective in future nanomaterial design, as well as a novel platform with higher stability and selectivity for the in vivo application of chemical sensing and clinical therapies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.